PDE9A Antibodies

Santa Cruz Biotechnology delivers a wide array of PDE9A monoclonal antibodies for research focused on understanding phosphodiesterase 9A in biological processes. PDE9A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PDE9A is an essential enzyme that regulates intracellular levels of cyclic nucleotides, particularly cGMP, which plays a critical role in signaling pathways related to cardiovascular function, neuronal signaling, and smooth muscle relaxation. Dysregulation of PDE9A has been implicated in various diseases, making it a significant target for therapeutic intervention. Understanding PDE9A function through molecular research can provide valuable insights into its role in health and disease. Researchers can explore PDE9A expression patterns across different tissues and cell types to better understand its biological significance. Advanced research techniques using PDE9A monoclonal antibodies enable detailed investigation of protein-protein interactions and cellular localization patterns. Santa Cruz Biotechnology monoclonal antibodies for PDE9A research support scientists worldwide in advancing our understanding of cellular signaling mechanisms and potential therapeutic applications.